Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.7%

23 terminated/withdrawn out of 297 trials

Success Rate

83.8%

-2.7% vs industry average

Late-Stage Pipeline

3%

9 trials in Phase 3/4

Results Transparency

0%

0 of 119 completed trials have results

Key Signals

28 recruiting20 withdrawn

Enrollment Performance

Analytics

N/A
207(92.0%)
Phase 2
8(3.6%)
Phase 3
6(2.7%)
Phase 4
3(1.3%)
Phase 1
1(0.4%)
225Total
N/A(207)
Phase 2(8)
Phase 3(6)
Phase 4(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (297)

Showing 20 of 297 trials
NCT07184866Not ApplicableNot Yet Recruiting

Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial

Role: lead

NCT07178366Not ApplicableNot Yet Recruiting

Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)

Role: lead

NCT07480005Recruiting

To Revisit the Yield of Staging Laparoscopy in Hepatopancreatobiliary Malignancies

Role: lead

NCT07480057Recruiting

Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry

Role: lead

NCT07465471Not ApplicableNot Yet Recruiting

Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis.

Role: lead

NCT06091345Not ApplicableCompleted

Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites

Role: lead

NCT07433881Not Yet Recruiting

Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis

Role: lead

NCT07422948Not ApplicableNot Yet Recruiting

Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure.

Role: lead

NCT07391267Not ApplicableNot Yet Recruiting

Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.

Role: lead

NCT05044663Completed

Liver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in MASLD Related Compensated Advanced Chronic Liver Disease.

Role: lead

NCT06831643Not ApplicableRecruiting

Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver Failure

Role: lead

NCT06768216Not ApplicableRecruiting

Effect of Indianized Version of Mediterranean Diet vs. Low Fat Diet on Hepatic Steatosis in Overweight Children and Adolescent With MASLD

Role: lead

NCT06047327Not ApplicableCompleted

EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver Disease

Role: lead

NCT07299110Not ApplicableRecruiting

Effect of Whey Protein Versus Egg Albumen Protein Challenge on Blood Ammonia Level in Patients of Decompensated Ethanol Related Cirrhosis.

Role: lead

NCT07263061Recruiting

Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries

Role: lead

NCT07268196Recruiting

Impact of Liver Transplantation on Sexual Life and Function

Role: lead

NCT06091787Not ApplicableCompleted

Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy

Role: lead

NCT06909188Recruiting

The Study of Association of Helicobacter Infections in Biliary Tract Cancers

Role: lead

NCT07270809Not Yet Recruiting

To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months.

Role: lead

NCT06515145Not ApplicableNot Yet Recruiting

High-volume Versus Standard Volume Plasma Exchange in Patients With Acute Liver Failure With Cerebral Edema

Role: lead